Therapeutic potential of LIF in multiple sclerosis

被引：35
|
作者：
Slaets, Helena [1 ,2 ]
Hendriks, Jerome J. A. [1 ,2 ]
Stinissen, Piet [1 ,2 ]
Kilpatrick, Trevor J. [3 ,4 ]
Hellings, Niels [1 ,2 ]
机构：
[1] Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium
[2] Transnat Univ Limburg, Sch Life Sci, Diepenbeek, Belgium
[3] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia
[4] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia
来源：
TRENDS IN MOLECULAR MEDICINE | 2010年 / 16卷 / 11期
关键词：
LEUKEMIA INHIBITORY FACTOR; LIMITS AUTOIMMUNE DEMYELINATION; CILIARY NEUROTROPHIC FACTOR; SPINAL-CORD-INJURY; NEURODEGENERATIVE CONDITIONS; SYNOVIAL-FLUID; MOUSE MODEL; STEM-CELLS; PHASE-II; CYTOKINE;
D O I：
10.1016/j.molmed.2010.08.007
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Therapies for multiple sclerosis (MS) reduce the relapse rate but are unable to stop neurological decline. Here, we evaluate the potential of leukemia inhibitory factor (LIF) as a novel therapeutic in diseases with a neurodegenerative and inflammatory component, such as MS. LIF, which can be a proinflammatory cytokine, can also modulate the immune response in a beneficial way. Recent evidence demonstrates a crucial role of LIF in neuroprotection and axonal regeneration as well as the prevention of demyelination. Finally, LIF is an important survival factor for stem cells and neuronal precursors. Therefore, we propose that LIF is a potential therapeutic candidate for MS.
引用
收藏
页码：493 / 500
页数：8
相关论文
共 50 条
  • [1] IMMUNOMODULATORY AND THERAPEUTIC PROPERTIES OF LIF IN MULTIPLE SCLEROSIS
    Janssens, K.
    Slaets, H.
    Baekelandt, V
    Van den Haute, C.
    Vanwijmeersch, B.
    Eijnde, Op't B.
    Stinissen, P.
    Hendriks, J.
    Hellings, N.
    GLIA, 2011, 59 : S140 - S140
  • [2] Therapeutic potential of lovastatin in multiple sclerosis
    Sena, A
    Pedrosa, R
    Morais, MG
    JOURNAL OF NEUROLOGY, 2003, 250 (06) : 754 - 755
  • [3] Therapeutic potential of curcumin for multiple sclerosis
    Qureshi, Munibah
    Al-Suhaimi, Ebtesam A.
    Wahid, Fazli
    Shehzad, Omer
    Shehzad, Adeeb
    NEUROLOGICAL SCIENCES, 2018, 39 (02) : 207 - 214
  • [4] Therapeutic potential of curcumin for multiple sclerosis
    Munibah Qureshi
    Ebtesam A. Al-Suhaimi
    Fazli Wahid
    Omer Shehzad
    Adeeb Shehzad
    Neurological Sciences, 2018, 39 : 207 - 214
  • [5] The therapeutic potential of cannabis in multiple sclerosis
    Baker, D
    Pryce, G
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 561 - 567
  • [6] Therapeutic potential of lovastatin in multiple sclerosis
    Armando Sena
    Rui Pedrosa
    M. Graça Morais
    Journal of Neurology, 2003, 250 : 754 - 755
  • [7] Tau in Multiple Sclerosis: A Review of Therapeutic Potential
    Hoehne, Carolin
    Stuve, Olaf
    Stopschinski, Barbara Elena
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2025, 27 (01)
  • [8] PPAR-γ: Therapeutic Potential for Multiple Sclerosis
    Drew, Paul D.
    Xu, Jihong
    Racke, Michael K.
    PPAR RESEARCH, 2008, 2008
  • [9] Multiple Sclerosis and Serotonin: Potential Therapeutic Applications
    San Hernandez, Aleyda M.
    Singh, Chetana
    Valero, Danel J.
    Nisar, Javariya
    Ramirez, Jose I. Trujillo
    Kothari, Karisma K.
    Isola, Sasank
    Gordon, Domonick K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [10] Therapeutic potential of carbon monoxide in multiple sclerosis
    Fagone, P.
    Mangano, K.
    Coco, M.
    Perciavalle, V.
    Garotta, G.
    Romao, C. C.
    Nicoletti, F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 167 (02): : 179 - 187
12345